1.89
price up icon1.61%   0.03
after-market After Hours: 1.90 0.01 +0.53%
loading
Seer Inc stock is traded at $1.89, with a volume of 205.97K. It is up +1.61% in the last 24 hours and up +10.53% over the past month. Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.
See More
Previous Close:
$1.86
Open:
$1.86
24h Volume:
205.97K
Relative Volume:
0.51
Market Cap:
$104.07M
Revenue:
$16.45M
Net Income/Loss:
$-73.60M
P/E Ratio:
-1.4771
EPS:
-1.2795
Net Cash Flow:
$-46.25M
1W Performance:
+0.53%
1M Performance:
+10.53%
6M Performance:
-12.50%
1Y Performance:
+0.00%
1-Day Range:
Value
$1.86
$1.92
1-Week Range:
Value
$1.82
$2.09
52-Week Range:
Value
$1.65
$2.41

Seer Inc Stock (SEER) Company Profile

Name
Name
Seer Inc
Name
Phone
650-453-0000
Name
Address
3800 BRIDGE PARKWAY, SUITE 102, REDWOOD CITY
Name
Employee
124
Name
Twitter
Name
Next Earnings Date
2026-05-13
Name
Latest SEC Filings
Name
SEER's Discussions on Twitter

Compare SEER vs VRTX, REGN, ARGX, ALNY, ONC

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
SEER icon
SEER
Seer Inc
1.89 102.42M 16.45M -73.60M -46.25M -1.2795
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
427.65 107.87B 12.32B 4.34B 3.19B 16.86
REGN icon
REGN
Regeneron Pharmaceuticals Inc
721.05 73.63B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
807.55 49.42B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
303.00 40.20B 3.71B 313.75M 465.38M 2.2571
ONC icon
ONC
Beone Medicines Ltd Adr
313.32 33.06B 5.36B 287.73M 924.18M 2.5229

Seer Inc Stock (SEER) Upgrades & Downgrades

Date Action Analyst Rating Change
Jul-05-23 Resumed JP Morgan Neutral
Jan-04-23 Downgrade BofA Securities Neutral → Underperform
Aug-11-22 Downgrade JP Morgan Overweight → Neutral
Oct-15-21 Resumed Cowen Outperform
Dec-29-20 Initiated BofA Securities Neutral
Dec-29-20 Initiated Cowen Outperform
Dec-29-20 Initiated JP Morgan Overweight
Dec-29-20 Initiated Morgan Stanley Equal-Weight
View All

Seer Inc Stock (SEER) Latest News

pulisher
May 05, 2026

Seer, Inc. Class A Common Stock (SEER) Stock Price Today & Analysis - Gotrade

May 05, 2026
pulisher
May 05, 2026

Canaccord Genuity initiates coverage of Seer (SEER) with buy recommendation - MSN

May 05, 2026
pulisher
May 04, 2026

Seer Appoints Anthony Bazarko as Chief Commercial Officer - TipRanks

May 04, 2026
pulisher
May 04, 2026

Anthony Bazarko joins Seer (NASDAQ: SEER) as chief commercial officer - Stock Titan

May 04, 2026
pulisher
May 04, 2026

Seer Initiated at Buy by Canaccord Genuity - Moomoo

May 04, 2026
pulisher
May 04, 2026

Invus-affiliated group reports 2.46M shares in Seer, Inc. (SEER) - Stock Titan

May 04, 2026
pulisher
May 04, 2026

Canaccord initiates Seer stock with buy rating on proteomics platform By Investing.com - Investing.com India

May 04, 2026
pulisher
May 04, 2026

Seer appoints Anthony Bazarko as chief commercial officer By Investing.com - Investing.com Australia

May 04, 2026
pulisher
May 04, 2026

Seer appoints Anthony Bazarko as chief commercial officer - Investing.com UK

May 04, 2026
pulisher
May 04, 2026

Canaccord Genuity initiated coverage on Seer with a new price target - Quantisnow

May 04, 2026
pulisher
May 04, 2026

Seer, Inc. Appoints Anthony Bazarko as Chief Commercial Officer - marketscreener.com

May 04, 2026
pulisher
May 04, 2026

Canaccord initiates Seer stock with buy rating on proteomics platform - Investing.com

May 04, 2026
pulisher
May 01, 2026

Seer, Inc. 2025 Annual Report: Executive Compensation, Governance, and Director Information - Minichart

May 01, 2026
pulisher
Apr 30, 2026

Board pay and severance terms detailed in Seer (NASDAQ: SEER) filing - Stock Titan

Apr 30, 2026
pulisher
Apr 29, 2026

Seer to Report First Quarter 2026 Financial Results on May 13, 2026 - Investing News Network

Apr 29, 2026
pulisher
Apr 29, 2026

Seer schedules May 13 webcast to discuss first-quarter results - Stock Titan

Apr 29, 2026
pulisher
Apr 29, 2026

The Radoff-JEC Group Responds to Seer, Inc.?s Rejection of Acquisition Proposal - marketscreener.com

Apr 29, 2026
pulisher
Apr 29, 2026

Seer (SEER) Shareholders Challenge Board's Rejection of Acquisition Proposal - GuruFocus

Apr 29, 2026
pulisher
Apr 29, 2026

The Radoff-JEC Group Responds to Seer, Inc.'s Rejection of April 24th Acquisition Proposal - Investing News Network

Apr 29, 2026
pulisher
Apr 29, 2026

The Radoff-JEC Group Responds to Seer, Inc.’s Rejection of April 24th Acquisition Proposal - Stock Titan

Apr 29, 2026
pulisher
Apr 28, 2026

Seer gets sweetened buyout offer from activist group - MSN

Apr 28, 2026
pulisher
Apr 27, 2026

Seer rejects $2.35 per share takeover bid from investor group By Investing.com - Investing.com UK

Apr 27, 2026
pulisher
Apr 27, 2026

Seer Board Rejects Takeover Bid, Affirms Independent Strategy - TipRanks

Apr 27, 2026
pulisher
Apr 27, 2026

Seer Board Unanimously Rejects $2.35/Share Revised Unsolicited Proposal as Significantly Undervaluing Company - TradingView

Apr 27, 2026
pulisher
Apr 27, 2026

Seer (NASDAQ: SEER) Board Rejects Radoff-JEC’s $2.35 Cash+CVR Offer - Stock Titan

Apr 27, 2026
pulisher
Apr 27, 2026

Seer Board of Directors Unanimously Rejects Revise Proposal from Radoff-JEC Group - marketscreener.com

Apr 27, 2026
pulisher
Apr 27, 2026

Seer denies investors' raised buyout offer, says it 'significantly undervalues' company - The Business Journals

Apr 27, 2026
pulisher
Apr 27, 2026

Bradley L. Radoff and Michael Torok cancelled the acquisition of remaining 93.8% stake in Seer, Inc.. - marketscreener.com

Apr 27, 2026
pulisher
Apr 27, 2026

Seer Board of Directors Unanimously Rejects Revised Unsolicited Proposal from Radoff-JEC Group - Investing News Network

Apr 27, 2026
pulisher
Apr 27, 2026

Seer (SEER) Board Rejects Revised Acquisition Proposal - GuruFocus

Apr 27, 2026
pulisher
Apr 27, 2026

Seer board says $2.35-a-share buyout offer undervalues company - Stock Titan

Apr 27, 2026
pulisher
Apr 27, 2026

Seer, Inc. (NASDAQ:SEER) Sees Large Decrease in Short Interest - MarketBeat

Apr 27, 2026
pulisher
Apr 26, 2026

Seer jumps 10% on $2.25 per share all-cash acquisition bid from activist group (update) - MSN

Apr 26, 2026
pulisher
Apr 25, 2026

Seer receives improved $2.35 per share takeover proposal By Investing.com - Investing.com Australia

Apr 25, 2026
pulisher
Apr 24, 2026

Seer (SEER) Faces Acquisition Proposal from Major Shareholders - GuruFocus

Apr 24, 2026
pulisher
Apr 24, 2026

The Radoff-JEC Group Submits Improved Non-Binding Proposal to Acquire Seer, Inc. - Investing News Network

Apr 24, 2026
pulisher
Apr 24, 2026

Activist group offers $2.35 per share to Seer (NASDAQ: SEER), seeks board change - Stock Titan

Apr 24, 2026
pulisher
Apr 24, 2026

Radoff-JEC Group Raises Bid for Seer to $2.35 Per Share - citybiz

Apr 24, 2026
pulisher
Apr 24, 2026

Seer receives improved $2.35 per share takeover proposal - Investing.com

Apr 24, 2026
pulisher
Apr 24, 2026

Radoff-Jec Group recently publicly accused the Seer, Inc. board of directors of failing to engage in any substantive communication regarding the acquisition proposal made by Radoff-Jec Group. - Bitget

Apr 24, 2026

Seer Inc Stock (SEER) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Seer Inc Stock (SEER) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Farokhzad Omid
CEO AND CHAIR
Feb 18 '26
Sale
1.99
24,385
48,646
3,349,064
Horn David R.
PRESIDENT & CFO
Nov 19 '25
Sale
1.97
6,797
13,400
436,802
Farokhzad Omid
CEO AND CHAIR
Nov 19 '25
Sale
1.97
33,838
66,708
1,238,230
Horn David R.
PRESIDENT & CFO
Aug 20 '25
Sale
2.04
6,827
13,955
436,802
Farokhzad Omid
CEO AND CHAIR
Aug 20 '25
Sale
2.04
33,992
69,483
1,272,068
Nishar Dipchand
Director
Jun 13 '25
Sale
2.08
30,253
62,935
49,204
$28.82
price up icon 1.77%
$50.72
price up icon 0.56%
$95.26
price down icon 0.25%
$137.09
price down icon 1.69%
$151.07
price up icon 2.62%
ONC ONC
$313.32
price up icon 5.32%
Cap:     |  Volume (24h):